Results 201 to 210 of about 2,617,462 (305)

8 Implication of the HIV-1 pol gene intragenic enhancer in myeloid-specific viral gene expression

Journal of Virus Eradication, 2017
R. Verdikt, L. Colin, C. Vanhulle, B. Van Driessche, A. Kula, V. Monceaux, N. Delacourt, A. David, A. Saez-Cirion, C. Van Lint   +9 more
doaj   +1 more source

Giant condyloma acuminatum in a patient with HIV infection: a case report. [PDF]

AIDS Res Ther
Wang C, Wang T, Gao L, Zhang Y, Liu Y, Jia G, Zhao Z, Li J, Kang W.   +8 more
europepmc   +1 more source

Urogenital Infection Risk Associated With SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Target Trial Emulation

Clinical Pharmacology &Therapeutics, EarlyView.
Although sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are recommended for patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), concerns regarding urogenital infections persist. Therefore, we evaluated the risk of urinary tract infection (UTI) and genital tract infection (GTI) after SGLT2i initiation in this population ...
Young‐Mi Ah, Junsung Nam, Jung Wook Youn, Yun Mi Yu, Soyoung Kang   +4 more
wiley   +1 more source

sVCAM-1 and Hematological Profiles Are Associated With CD4-Defined Disease Status in HIV Infection. [PDF]

J Med Virol
Almeida-Silva B, da Silva-Junior CD, Vaitkevicius-Antão V, Aciole MR, Márcia da Silva M, Rocha Vilela Moura LC, Ramos de Araujo PS, Christiane da Silva Rabello M, Barros de Lorena VM.   +8 more
europepmc   +1 more source

Diagnosing HIV infection [PDF]

Clinical Medicine, 2003
openaire   +2 more sources

Evaluating Vaginal Microbiome Effects on Antiretroviral Exposure in the Female Genital Tract Using Pharmacometric and Machine Learning Approaches

Clinical Pharmacology &Therapeutics, EarlyView.
Antiretroviral pre‐exposure prophylaxis (PrEP) is less effective in women than expected, partly because drug exposure within the female genital tract is variable and may be influenced by the vaginal microbiome. We developed an integrated pharmacometrics and machine learning framework to evaluate associations between vaginal microbiome composition and ...
Diqin Yan, Lindsey B. Collins, Christopher Staley, Flavia Kiweewa Matovu, Pamala Jacobson, Melanie Nicol, Shen Cheng   +6 more
wiley   +1 more source

Advances in Immune-Based Approaches for the Cure of HIV Infection. [PDF]

Drugs
Wagner JA, Sandel DA, Deitchman AN, Rutishauser RL, Deeks SG, Peluso MJ.   +5 more
europepmc   +1 more source

Unbound Intrinsic Formation Clearance of 6β‐Hydroxycortisol Is a Useful Biomarker of CYP3A4 Activity during Pregnancy

Clinical Pharmacology &Therapeutics, EarlyView.
Pregnancy results in multiple physiological changes that impact drug disposition. For example, hepatic CYP3A activity and renal transporter‐mediated clearance increase in late pregnancy, but the time course of these changes across pregnancy is not known.
Aurora K Authement, Mary F Hebert, Emily E Fay, Nina Isoherranen   +3 more
wiley   +1 more source

Not Tuberculosis After All: The "Hare-Raising Case" of Tularemia in a Patient With Advanced HIV Infection. [PDF]

Case Rep Infect Dis
Geerdink JX, Welzen BJV.
europepmc   +1 more source

Establishment of pediatric reference ranges for circulating naïve and memory T and B cell subsets guided by the human immunophenotyping consortium standardization initiative: A large, single center U.S. experience

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Our knowledge of the immune system continues to expand at a rapid pace, and this coupled with technological advances now enables us to interrogate both the breadth and the depth of the immune response at levels without precedent. This has also facilitated rapidly integrating some of this carefully vetted knowledge into clinical practice ...
Aaruni Khanolkar, Aisha Ahmed
wiley   +1 more source